Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
| Report ID | 577 |
| Drug Identification Number | 02308452 |
| Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Common or Proper name | PIPERACILLIN - TAZOBACTUM |
| Company Name | APOTEX INC |
| Market Status | DORMANT |
| Active Ingredient(s) | PIPERACILLIN TAZOBACTAM |
| Strength(s) | 3.0G 0.375G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 30 ML |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2016-09-07 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2018-09-12 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.